Eris Lifesciences Files FY26 Business Responsibility and Sustainability Report

Eris Lifesciences Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, along with an independent reasonable assurance statement. The report details the company's corporate identity, registered and corporate office information, and contact details for BRSR queries. It outlines the company's business activities, primarily pharmaceutical manufacturing and marketing, which account for 100% of its turnover. The report also covers operational details, employee statistics, and market reach, emphasizing its domestic focus with no export activities. The assurance provider for the BRSR Core KPIs is B Kabra and Co, who provided reasonable assurance.